241 related articles for article (PubMed ID: 25835513)
1. Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers.
Jacobson RM; Grill DE; Oberg AL; Tosh PK; Ovsyannikova IG; Poland GA
Hum Vaccin Immunother; 2015; 11(4):961-9. PubMed ID: 25835513
[TBL] [Abstract][Full Text] [Related]
2. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
Bai Y; Shi N; Lu Q; Yang L; Wang Z; Li L; Han H; Zheng D; Luo F; Zhang Z; Ai X
Hum Vaccin Immunother; 2015; 11(7):1648-53. PubMed ID: 26083828
[TBL] [Abstract][Full Text] [Related]
3. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
4. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
[TBL] [Abstract][Full Text] [Related]
5. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
[TBL] [Abstract][Full Text] [Related]
7. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
[TBL] [Abstract][Full Text] [Related]
8. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children.
Black S; Nicolay U; Vesikari T; Knuf M; Del Giudice G; Della Cioppa G; Tsai T; Clemens R; Rappuoli R
Pediatr Infect Dis J; 2011 Dec; 30(12):1081-5. PubMed ID: 21983214
[TBL] [Abstract][Full Text] [Related]
9. Response to a monovalent 2009 influenza A (H1N1) vaccine.
Greenberg ME; Lai MH; Hartel GF; Wichems CH; Gittleson C; Bennet J; Dawson G; Hu W; Leggio C; Washington D; Basser RL
N Engl J Med; 2009 Dec; 361(25):2405-13. PubMed ID: 19745216
[TBL] [Abstract][Full Text] [Related]
10. A clinical trial to assess the immunogenicity and safety of Inactivated Influenza Vaccine (Whole Virion) IP (Pandemic Influenza (H1N1) 2009 Monovalent Vaccine; VaxiFlu-S™) in healthy Indian adult population.
Kubavat AH; Mittal R; Patel PM; Jarsaniya DH; Pawar PR;
J Postgrad Med; 2011; 57(2):102-8. PubMed ID: 21654130
[TBL] [Abstract][Full Text] [Related]
11. Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine.
Sun Y; Bian C; Xu K; Hu W; Wang T; Cui J; Wu H; Ling Z; Ji Y; Lin G; Tian L; Zhou Y; Li B; Hu G; Yu N; An W; Pan R; Zhou P; Leng Q; Huang Z; Ma X; Sun B
PLoS One; 2010 Dec; 5(12):e14270. PubMed ID: 21151563
[TBL] [Abstract][Full Text] [Related]
12. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
13. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.
Luytjes W; Enouf V; Schipper M; Gijzen K; Liu WM; van der Lubben M; Meijer A; van der Werf S; Soethout EC
Vaccine; 2012 Jul; 30(35):5262-9. PubMed ID: 22691431
[TBL] [Abstract][Full Text] [Related]
14. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
[TBL] [Abstract][Full Text] [Related]
15. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
16. Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.
Tunheim G; Laake I; Robertson AH; Waalen K; Hungnes O; Naess LM; Cox RJ; Mjaaland S; Trogstad L
Influenza Other Respir Viruses; 2019 Mar; 13(2):191-200. PubMed ID: 30536590
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.
Zhan Y; Yang Z; Li L; Ye D; Wu H; Fu R; Zhao S; Wang Y; Zhou R; Chen R
Jpn J Infect Dis; 2011; 64(3):190-4. PubMed ID: 21617301
[TBL] [Abstract][Full Text] [Related]
18. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
Engelhard D; Zakay-Rones Z; Shapira MY; Resnick I; Averbuch D; Grisariu S; Dray L; Djian E; Strauss-Liviatan N; Grotto I; Wolf DG; Or R
Vaccine; 2011 Feb; 29(9):1777-82. PubMed ID: 21216315
[TBL] [Abstract][Full Text] [Related]
19. Antibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time.
Huang KA; Chang SC; Huang YC; Chiu CH; Lin TY
Sci Rep; 2017 Jan; 7():40027. PubMed ID: 28098157
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
Uno S; Kimachi K; Matsuo F; Miyazaki K; Oohama A; Kei J; Nishimura T; Odoh K; Kino Y
Microbiol Immunol; 2012 Dec; 56(12):810-6. PubMed ID: 23009167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
